Effectiveness of telerehabilitation in managing chronic low back pain: a pragmatic randomized controlled non-inferiority trial.

Int J Med InformJun 10, 2026 (epub)

Fayez Alahmri, Hani A Alkhawajah, Shibili Nuhmani et al.

✦ AI-curated · Sources linked

In 30 seconds

This pragmatic randomized controlled trial evaluated the effectiveness of telerehabilitation (TR) compared to conventional rehabilitation in 50 adults with chronic low back pain (CLBP). The study found that while TR did not demonstrate non-inferiority for pain intensity, it was non-inferior for disability, with an adjusted mean difference of -0.82 points on the Oswestry Disability Index.

Key findings

  • TR did not show non-inferiority for pain intensity within the pre-specified margin.
  • TR was non-inferior to conventional rehabilitation for disability with an adjusted mean difference of -0.82 points.
  • No significant between-group differences were observed for other secondary outcomes.

Why it matters

Understanding the effectiveness of telerehabilitation provides clinicians with alternative management strategies for patients with chronic low back pain, especially in contexts where in-person visits may be challenging.

Source

Published in Int J Med Inform. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Physical Medicine & Rehabilitation

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.